SAR of benzoylpyridines and benzophenones as p38α MAP kinase inhibitors with oral activity

被引：38

作者：

Revesz, L ^{[1
]}

Blum, E ^{[1
]}

Di Padova, FE ^{[1
]}

Buhl, T ^{[1
]}

Feifel, R ^{[1
]}

Gram, H ^{[1
]}

Hiestand, P ^{[1
]}

Manning, U ^{[1
]}

Rucklin, G ^{[1
]}

机构：

[1] Novartis Inst Biomed Res Arthrit & Bone Metab, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2004年 / 14卷 / 13期

关键词：

D O I：

10.1016/j.bmcl.2004.03.111

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Benzoylpyridines and benzophenones were synthesized and evaluated in vitro as p38alpha inhibitors and in vivo in several models of rheumatoid arthritis. Oral activity was found to depend upon substitution: 1,1-dimethylpropynylamine substituted benzophenone 10b (IC50: 14 nM) and pyridinoyl substituted benzimidazole 17b (IC50: 21 nM) showed highest efficacy and selectivity with ED50S of 9.5 and 8.6 mg/kg po in CIA. (C) 2004 Elsevier Ltd. All rights reserved.

引用

页码：3601 / 3605

页数：5

共 50 条

[41] Allosteric p38 kinase inhibitors
Norman, Peter
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (10) : 1443 - 1448
[42] Synthesis and SAR of p38 kinase inhibitors from the urea class.
Dumas, J
Bhargava, A
Bobko, M
Brennan, C
Hatoum-Mokdad, H
Housley, TJ
Johnson, JS
Kingery-Wood, J
Lee, W
Lowinger, TB
Monahan, MK
Natero, R
Ranges, GE
Redman, AM
Riedl, B
Schoenleber, R
Scott, WJ
Shrikhande, A
Sibley, R
Smith, RA
Turner, T
Wilhelm, SM
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U562 - U562
[43] Inhibition of p38 MAP kinase activity enhances axonal regeneration
Myers, RR
Sekiguchi, Y
Kikuchi, S
Scott, B
Medicherla, S
Protter, A
Campana, WM
[J]. EXPERIMENTAL NEUROLOGY, 2003, 184 (02) : 606 - 614
[44] Design and synthesis of 4-azaindoles as inhibitors of p38 MAP kinase
Trejo, A
Arzeno, H
Browner, M
Chanda, S
Cheng, S
Comer, DD
Dalrymple, SA
Dunten, P
Lafargue, J
Lovejoy, B
Freire-Moar, J
Lim, J
Mcintosh, J
Miller, J
Papp, E
Reuter, D
Roberts, R
Sanpablo, F
Saunders, J
Song, K
Villasenor, A
Warren, SD
Welch, M
Weller, P
Whiteley, PE
Zeng, L
Goldstein, DM
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4702 - 4713
[45] Effects of p38 MAP Kinase Inhibitors on the Differentiation and Maturation of Erythroid Progenitors
Dalmas, Deidre A.
Tierney, Lauren A.
Zhang, Cindy
Narayanan, Padma K.
Boyce, Rogely W.
Schwartz, Lester W.
Frazier, Kendall S.
Scicchitano, Marshall S.
[J]. TOXICOLOGIC PATHOLOGY, 2008, 36 (07) : 958 - 971
[46] Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase
Cumming, JG
McKenzie, CL
Bowden, SG
Campbell, D
Masters, DJ
Breed, J
Jewsbury, PJ
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) : 5389 - 5394
[47] Discovery and design of novel benzimidazolone as inhibitors of p38 MAP kinase.
Hammach, A
Ralph, M
Corbo, F
Barbosa, A
Liu, PR
Soleymanzadeh, F
Goldberg, D
Sarko, C
Mckibben, B
Moss, N
Hao, MH
White, A
Qian, K
Pargellis, C
Kroe, R
Wildeson, J
Nelson, R
Fadra, T
Capolino, A
Kashem, M
Patnaude, L
Madwed, J
Torcellini, C
Kaplita, P
Farrel, T
Hu, HB
Yazdania, M
Kavanaugh, K
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
[48] 4-azaindoles: Novel inhibitors of p38 MAP kinase.
Trejo, A
Arzeno, H
Browner, M
Cheng, SA
Corner, DD
Dalrymple, S
Freire-Moar, J
Lim, J
Mcintosh, J
Miller, J
Myers, PL
Saunders, J
Sjogren, EB
Spellmyer, D
Warren, SD
Whiteley, PE
Zeng, L
Goldstein, DM
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U59 - U59
[49] Binding modes of known classes of p38 MAP kinase inhibitors.
Moss, N
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U437
[50] Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons
Zawada, WM
Meintzer, MK
Rao, P
Marotti, J
Wang, XM
Esplen, JE
Clarkson, ED
Freed, CR
Heidenreich, KA
[J]. BRAIN RESEARCH, 2001, 891 (1-2) : 185 - 196

← 1 2 3 4 5 →